FDA Approved: NABUMETONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nabumetone filed by Lupin Pharmaceuticals, indicating an update to the drug's labeling or formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)